Specify a stock or a cryptocurrency in the search bar to get a summary
Stayble Therapeutics AB
4K4Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. Address: Lennart Torstenssonsgatan 6, Gothenburg, Sweden, 412 56
Analytics
WallStreet Target Price
–P/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures 4K4
Dividend Analytics 4K4
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 4K4
Stock Valuation 4K4
Financials 4K4
Results | 2019 | Dynamics |